University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Cyproterone tablets
Status: Amber Dabigatran capsules

Following diagnosis of AF – use in line NICE and toolkit, initiation/recommendation by haematologist, transfer to GP with RICaD. For the treatment and secondary prevention of DVT and/or PE - use in line with NICE. Initiation/recommendation by haematologist, transfer to GP with RICaD

Adults only

Status: Amber Danazol capsules

Hereditary angiodema (off label)

Status: Amber Dantrolene capsules
Status: Amber Dapagliflozin#Amber
Status: Amber Degarelix injection

Supported by ESCA

Status: Amber Demeclocycline capsules

For the treatment of hyponatraemia resulting from inappropriate secretion of antidiuretic hormone. Unlicensed.

Status: Amber Denosumab injection (Prolia®)

ESCA

Status: Amber Dermablend®
Status: Amber Dermacolor®
Building healthier lives
Back to top